MedTrace Logo

TMJ NextGen Pilot Study to Treat Subjects With Bruxism

NCT02446288 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-18

No results posted yet for this study

Summary

The study is an open-label, prospective, multicenter, randomized, two treatment parallel, comparison study of the TMJ NextGeneration and DSG Relaxer in the reduction of nocturnal bruxism episodes in subjects diagnosed with sleep bruxism.

Conditions

  • Bruxism

Interventions

DEVICE

TMJ Next Generation

DEVICE

DSG Relaxer

Sponsors & Collaborators

  • TMJ Health

    collaborator INDUSTRY

  • Cardiox Corporation

    lead INDUSTRY

Principal Investigators

  • Simon Blackburn, CCRA · Cardiox Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-10-31
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02446288 on ClinicalTrials.gov